Condition
ICU-acquired Weakness
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (5)
Trial Status
Completed3
Withdrawn1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07362862Not ApplicableNot Yet Recruiting
MyokinE100 System: Closed Loop Electrical Muscle Stimulation to Mitigate ICU Acquired Weakness in Medical ICU Patients
NCT06944431Not ApplicableCompleted
Using Continuous Passive Motion to Prevent Ankle Problems in ICU Patients
NCT03529656Not ApplicableCompletedPrimary
The Early Rehabilitation Program in Post-LT Pts
NCT03071354Not ApplicableWithdrawn
Improving Muscle Function in Nutritionally at Risk, Elderly Patients
NCT03055949Not ApplicableCompletedPrimary
Safety and Efficacy of an Early Rehabilitation Program in Surgical Intensive Care Unit
Showing all 5 trials